Document Detail


Safety and efficacy of prolonged use of unfractionated heparin after percutaneous coronary intervention.
MedLine Citation:
PMID:  19770793     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
The current guidelines for percutaneous coronary intervention do not address the prolonged postprocedural use of unfractionated heparin (UFH) to prevent acute occlusion. However, recently published small studies have yielded mixed results, leaving the question unanswered. Hence, we performed a meta-analysis of the existing evidence to assess the safety and efficacy of prolonged infusion of UFH after percutaneous coronary intervention. A systematic review of literature revealed seven studies involving 2412 patients. End points analyzed were ischemic complications (acute closure, myocardial infarction, and repeat revascularization) and major vascular complications (hematoma, arteriovenous fistula, pseudoaneurysm, and retroperitoneal bleed). Because the studies were homogenous for outcomes, combined relative risks across all the studies and the 95% confidence intervals were computed using the Mantel-Haenszel fixed-effect model. A two-sided alpha error <0.05 was considered to be statistically significant. There were no significant differences in patient demographics between both groups. Compared with placebo, the risk of major vascular complication was significantly higher in patients getting postprocedural UFH for prolonged hours (relative risk, 2.24; confidence interval, 1.68-3.48; P = 0.001). However, the risk of ischemic complications was similar in both groups (relative risk, 0.95; confidence interval, 0.46-1.96; P = 0.89). The meta-analysis suggests that routine infusion of UFH after uncomplicated percutaneous coronary intervention may result in increased vascular complications without any reduction in incidence of ischemic complications.
Authors:
Param Puneet Singh; Rohit Arora; Mukesh Singh; Updesh Singh Bedi; Sasikanth Adigopula; Sarabjeet Singh; Rohit Bhuriya; Janos Molnar; Sandeep Khosla
Related Documents :
9834303 - A clinical trial comparing three antithrombotic-drug regimens after coronary-artery ste...
2083863 - Heparin and antiaggregating therapy in unstable angina.
19631653 - The extracellular matrix as a modulator of the inflammatory and reparative response fol...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of therapeutics     Volume:  17     ISSN:  1536-3686     ISO Abbreviation:  Am J Ther     Publication Date:    2010 Nov-Dec
Date Detail:
Created Date:  2010-11-09     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9441347     Medline TA:  Am J Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  535-42     Citation Subset:  IM    
Affiliation:
Section of Cardiology, Department of Internal Medicine, Chicago Medical School/Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA. drparamsingh@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antibiotics for the treatment of primary sclerosing cholangitis.
Next Document:  Switching From Atorvastatin to Simvastatin in Patients at High Cardiovascular Risk: Effects on Low-D...